Singular Genomics Systems Inc logo

OMIC

Singular Genomics Systems Inc

$3.01

Earnings Summary

Revenue
$0Mn
Net Profits
$-22.01Mn
Net Profit Margins
-Inf%
PE Ratio
50.25

Highlights

Revenue:

Singular Genomics Systems Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, Singular Genomics Systems Inc has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Singular Genomics Systems Inc’s net profit jumped 8.01% since last year same period to $-22.01Mn in the Q1 2022. On a quarterly growth basis, Singular Genomics Systems Inc has generated -11.37% fall in its net profits since last 3-months.

Net Profit Margins:

Singular Genomics Systems Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2022. On a quarterly growth basis, Singular Genomics Systems Inc has generated NaN% jump in its net profit margins since last 3-months.

PE Ratio:

Singular Genomics Systems Inc’s price-to-earnings ratio after this Q1 2022 earnings stands at 50.25.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Singular Genomics Systems Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.33
EPS Estimate Current Year
-0.33

Highlights

EPS Estimate Current Quarter:

Singular Genomics Systems Inc’s earning per share (EPS) estimates for the current quarter stand at -0.33 - a -6.45% fall from last quarter’s estimates.

EPS Estimate Current Year:

Singular Genomics Systems Inc’s earning per share (EPS) estimates for the current year stand at -0.33.

Key Ratios

Key ratios of the Singular Genomics Systems Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.31
Return on Assets (ROA)
-0.14
Return on Equity (ROE)
-0.25
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Singular Genomics Systems Inc’s earning per share (EPS) jumped 10.17% since last year same period to -0.31 in the Q1 2022. This indicates that the Singular Genomics Systems Inc has generated 10.17% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Singular Genomics Systems Inc’s return on assets (ROA) stands at -0.14.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Singular Genomics Systems Inc’s return on equity (ROE) stands at -0.25.

Dividend Per Share (DPS):

Singular Genomics Systems Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-10
-0.33
-0.31
6.06%

Company Information

Organisation
Singular Genomics Systems Inc
Employees
138